Nordea Investment Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-50,859
| Closed | -$1.41M | – | 884 |
|
|
2025
Q3 | $1.41M | Sell |
50,859
-777
| -2% | -$23.9K | ﹤0.01% | 787 |
|
|
2025
Q2 | $1.58M | Buy |
51,636
+30
| +0.1% | +$852 | ﹤0.01% | 765 |
|
|
2025
Q1 | $1.43M | Buy |
51,606
+1,156
| +2% | +$36.6K | ﹤0.01% | 755 |
|
|
2024
Q4 | $1.81M | Buy |
50,450
+2,723
| +6% | +$102K | ﹤0.01% | 700 |
|
|
2024
Q3 | $1.8M | Sell |
47,727
-2,742
| -5% | -$113K | ﹤0.01% | 710 |
|
|
2024
Q2 | $2.3M | Sell |
50,469
-9,028
| -15% | -$415K | ﹤0.01% | 678 |
|
|
2024
Q1 | $2.9M | Sell |
59,497
-595
| -1% | -$29.1K | ﹤0.01% | 649 |
|
|
2023
Q4 | $3.23M | Sell |
60,092
-2,188
| -4% | -$111K | ﹤0.01% | 627 |
|
|
2023
Q3 | $3.65M | Sell |
62,280
-832
| -1% | -$52K | 0.01% | 573 |
|
|
2023
Q2 | $3.97M | Sell |
63,112
-7,558
| -11% | -$481K | 0.01% | 565 |
|
|
2023
Q1 | $4.45M | Sell |
70,670
-77
| -0.1% | -$4.59K | 0.01% | 543 |
|
|
2022
Q4 | $3.77M | Sell |
70,747
-4,300
| -6% | -$233K | 0.01% | 574 |
|
|
2022
Q3 | $4.25M | Sell |
75,047
-815
| -1% | -$53.9K | 0.01% | 551 |
|
|
2022
Q2 | $5.46M | Sell |
75,862
-3,744
| -5% | -$279K | 0.01% | 510 |
|
|
2022
Q1 | $6.34M | Buy |
79,606
+1,399
| +2% | +$126K | 0.01% | 538 |
|
|
2021
Q4 | $7.93M | Sell |
78,207
-582
| -0.7% | -$58.1K | 0.01% | 472 |
|
|
2021
Q3 | $7.22M | Sell |
78,789
-938
| -1% | -$90.2K | 0.01% | 510 |
|
|
2021
Q2 | $8.17M | Buy |
79,727
+7,458
| +10% | +$749K | 0.01% | 457 |
|
|
2021
Q1 | $7.08M | Sell |
72,269
-2,141
| -3% | -$195K | 0.01% | 461 |
|
|
2020
Q4 | $5.74M | Buy |
74,410
+15,212
| +26% | +$1.18M | 0.01% | 525 |
|
|
2020
Q3 | $4.34M | Sell |
59,198
-57,632
| -49% | -$4.62M | 0.01% | 525 |
|
|
2020
Q2 | $8.34M | Sell |
116,830
-20,780
| -15% | -$1.63M | 0.01% | 523 |
|
|
2020
Q1 | $8.03M | Sell |
137,610
-16,561
| -11% | -$1.15M | 0.02% | 341 |
|
|
2019
Q4 | $12.2M | Sell |
154,171
-299
| -0.2% | -$22K | 0.02% | 320 |
|
|
2019
Q3 | $10.7M | Buy |
154,470
+76,914
| +99% | +$5.16M | 0.02% | 330 |
|
|
2019
Q2 | $6.16M | Buy |
77,556
+18,543
| +31% | +$1.47M | 0.01% | 398 |
|
|
2019
Q1 | $4.95M | Sell |
59,013
-3,302
| -5% | -$345K | 0.01% | 577 |
|
|
2018
Q4 | $7.34M | Buy |
62,315
+34,500
| +124% | +$3.99M | 0.02% | 424 |
|
|
2018
Q3 | $3.35M | Sell |
27,815
-220,448
| -89% | -$27.4M | 0.01% | 789 |
|
|
2018
Q2 | $28.6M | Sell |
248,263
-106,338
| -30% | -$11.6M | 0.07% | 197 |
|
|
2018
Q1 | $30.5M | Buy |
354,601
+10,458
| +3% | +$810K | 0.07% | 173 |
|
|
2017
Q4 | $25.5M | Sell |
344,143
-74
| -0% | -$4.95K | 0.06% | 188 |
|
|
2017
Q3 | $19.9M | Buy |
344,217
+8,768
| +3% | +$518K | 0.05% | 213 |
|
|
2017
Q2 | $21.5M | Buy |
335,449
+16,307
| +5% | +$1M | 0.05% | 194 |
|
|
2017
Q1 | $18.4M | Buy |
319,142
+15,294
| +5% | +$913K | 0.05% | 206 |
|
|
2016
Q4 | $18.6M | Buy |
303,848
+3,946
| +1% | +$257K | 0.05% | 214 |
|
|
2016
Q3 | $20.7M | Buy |
299,902
+289,718
| +2,845% | +$19.1M | 0.05% | 194 |
|
|
2016
Q2 | $567K | Buy |
+10,184
| New | +$614K | ﹤0.01% | 733 |
|
Other funds holding USNA
NCM
Nordea Investment Management's USNA Position: Q4 2025 in Review
Nordea Investment Management sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 50,859 shares — an estimated $1.41M sold.
Nordea Investment Management first reported a position in USNA in Q2 2016 and held it in 38 quarters. The position peaked at $30.5M in Q1 2018. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.
- Nordea Investment Management reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
- Nordea Investment Management sold 50,859 Usana Health Sciences shares in Q4 2025, an estimated $1.41M.
- Nordea Investment Management first reported a position in Usana Health Sciences in Q2 2016 and held it in 38 quarters.
- Nordea Investment Management's Usana Health Sciences position peaked at $30.5M in Q1 2018.
- 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.
Based on Nordea Investment Management's 13F filing for Q4 2025, filed 8 Jan 2026.